[Form 4] Fathom Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Eos Energy Enterprises, Inc. (EOSE) – Form 144 filing discloses a proposed insider sale of common stock.

• Seller & broker: 47,254 common shares are to be sold for the account of Nathan Kroeker through UBS Financial Services Inc., Eleven Madison Ave., New York.
• Transaction size: Aggregate market value is $243,358.10, representing roughly 0.02 % of the 227,589,833 shares outstanding.
• Planned timing & venue: Sale is targeted for 07 / 08 / 2025 on the Nasdaq.
• Source of shares: Shares derive from RSU vesting on 07 / 05 / 2025; 47,254 units vested on that date.
• Recent selling activity: Over the last three months Kroeker sold 152,856 shares on 05 / 16 / 2025 for $1,048,853 and 24,124 shares on 07 / 07 / 2025 for $125,801.84.

The filing is a notice only; execution depends on market conditions, and Rule 144 limits apply. The volume is immaterial versus total shares, but the continued disposition may be monitored by investors assessing insider sentiment.

Positive

• Minimal dilution risk: 47,254 shares represent only 0.02 % of outstanding stock.
• Regulatory transparency: Timely Form 144 filing signals compliance with SEC disclosure requirements.

Negative

• Continued insider selling: 224k shares sold/registered within three months may be viewed as a bearish sentiment indicator.
• Lack of context: Filing provides no information on company performance or a 10b5-1 plan, leaving motives open to interpretation.

Insights

Securities Analyst

TL;DR: Small Rule 144 sale (47k) by insider; negligible dilution, mildly negative signal.

The proposed sale equals just 0.02 % of shares outstanding, so supply impact is de minimis. However, it continues a pattern of insider monetisation—roughly 224k shares disposed over three months for $1.4 million. While Rule 144 filings are routine, clustering of sales can be interpreted as a weak confidence signal. No operational metrics are disclosed, so valuation impact is limited to perception. Overall I classify the filing as neutral-to-slightly negative given its small scale.

Corporate Governance Expert

TL;DR: Routine compliance filing; transparency positive, insider selling optics mixed.

Form 144 demonstrates adherence to securities rules and likely ties to RSU vesting, indicating normal compensation realisation. Public disclosure via EDGAR enhances governance transparency. Still, serial sales within 90 days can draw scrutiny from investors focused on alignment of interests. Absence of a disclosed 10b5-1 plan leaves motives opaque. From a governance standpoint, the event is not materially impactful, but monitoring future filings is prudent.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Giuggio Samantha

(Last) (First) (Middle)

C/O FATHOM HOLDINGS INC.

2500 REGENCY PARKWAY DRIVE, SUITE 300

(Street)

CARY NC 27518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fathom Holdings Inc. [ FTHM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Broker Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/03/2025		S(1)		2,146	D	$1.3814(2)	102,543	D(3)
Common Stock								5,424	I	Reporting Person's Husband

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares sold to cover taxes upon the vesting of restricted stock on June 29, 2025.

2. The reported securities were sold in multiple transactions at prices ranging from $1.38 to $1.4085. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

3. Of these shares, 4,634 shares were issued pursuant to a restricted stock award, and are restricted and vest in full on March 30, 2026.

	/s/ Donald R. Reynolds, by Power of Attorney	07/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many EOSE shares are being registered for sale?

The Form 144 covers 47,254 common shares.

What is the estimated market value of the planned EOSE sale?

The aggregate market value is $243,358.10.

When is the planned sale date for the EOSE shares?

The filer lists an approximate sale date of 07/08/2025.

Which broker will handle the EOSE share sale?

Shares are to be sold through UBS Financial Services Inc. in New York.

What insider selling activity occurred in the past 3 months?

152,856 shares were sold on 05/16/2025 for $1,048,853, and 24,124 shares on 07/07/2025 for $125,801.84.

What is the source of the shares being sold under this Form 144?

The shares resulted from RSU vesting on 07/05/2025.